Related references
Note: Only part of the references are listed.Bempedoic Acid (ETC-1002): ATP Citrate Lyase Inhibitor Review of a First-in-Class Medication with Potential Benefit in Statin-Refractory Cases
Nicole K. Zagelbaum et al.
CARDIOLOGY IN REVIEW (2019)
Associations of statin use with glycaemic traits and incident type 2 diabetes
Fariba Ahmadizar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Modifiable Risk Factors in Young Adults With First Myocardial Infarction
Srikanth Yandrapalli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Statin users have an elevated risk of dysglycemia and new-onset-diabetes
Victoria A. Zigmont et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
Statin Toxicity Mechanistic Insights and Clinical Implications
Natalie C. Ward et al.
CIRCULATION RESEARCH (2019)
Drug Therapy of Dyslipidemia in the Elderly
Srikanth Yandrapalli et al.
DRUGS & AGING (2019)
Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis
J. Y. Cui et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2018)
Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort
Sang-Eun Lee et al.
PLOS ONE (2018)
Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus
Srikanth Yandrapalli et al.
POSTGRADUATE MEDICINE (2017)
Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention
Yogita Rochlani et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
Jill P. Crandall et al.
BMJ OPEN DIABETES RESEARCH & CARE (2017)
Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes A Meta-analysis
Luca A. Lotta et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients
Rishi Sukhija et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Rosuvastatin Treatment Affects Both Basal and Glucose-Induced Insulin Secretion in INS-1 832/13 Cells
Vishal A. Salunkhe et al.
PLOS ONE (2016)
Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
Henna Cederberg et al.
DIABETOLOGIA (2015)
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
Joost Besseling et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I. Swerdlow et al.
LANCET (2015)
Statins and the Risk of Diabetes: Evidence From a Large Population-Based Cohort Study
Giovanni Corrao et al.
DIABETES CARE (2014)
Different Time Trends of Caloric and Fat Intake Between Statin Users and Nonusers Among US Adults Gluttony in the Time of Statins?
Takehiro Sugiyama et al.
JAMA INTERNAL MEDICINE (2014)
Statin induced diabetes and its clinical implications
Umme Aiman et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2014)
Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
Eliano Pio Navarese et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Statins and risk of treated incident diabetes in a primary care population
Nur Lisa Zaharan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes
Chih-Hao Wang et al.
FEBS JOURNAL (2013)
Risk of incident diabetes among patients treated with statins: population based study
Aleesa A. Carter et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Statins for the primary prevention of cardiovascular disease
Fiona Taylor et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative
Annie L. Culver et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes-the CORALL study
S. Simsek et al.
DIABETIC MEDICINE (2012)
Statins, Risk of Diabetes, and Implications on Outcomes in the General Population
Kang-Ling Wang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
Paul M. Ridker et al.
LANCET (2012)
Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins
P. Sirvent et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Mitochondrial dysfunction in pancreatic β cells
Sachin Supale et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Pitavastatin: Clinical effects from the LIVES Study
Tamio Teramoto
ATHEROSCLEROSIS SUPPLEMENTS (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin Results From 3 Large Randomized Clinical Trials
David D. Waters et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
E. J. Mills et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Sarcopenia Exacerbates Obesity-Associated Insulin Resistance and Dysglycemia: Findings from the National Health and Nutrition Examination Survey III
Preethi Srikanthan et al.
PLOS ONE (2010)
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Swapnil N. Rajpathak et al.
DIABETES CARE (2009)
Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Marc Y. Donath et al.
PHYSIOLOGY (2009)
Type 2 diabetes mellitus and skeletal muscle metabolic function
Esther Phielix et al.
PHYSIOLOGY & BEHAVIOR (2008)
Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control
M. Nakata et al.
DIABETOLOGIA (2006)
Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients
H Mabuchi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2005)
Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men -: A randomized controlled trial
A Jula et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
